Logo for scPharmaceuticals Inc

scPharmaceuticals Investor Relations Material

Latest events

Logo for scPharmaceuticals Inc

Q4 2023

scPharmaceuticals
Logo for scPharmaceuticals

Q4 2023

13 Mar, 2024
Logo for scPharmaceuticals

Q3 2023

8 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from scPharmaceuticals Inc

Access all reports
ScPharmaceuticals Inc. engages in the development and commercialization of various pharmaceutical products. It focuses on developing, manufacturing, marketing and selling of pharmaceutical products used by clinical medicine fields, including antibiotics and analgesics. The company's product portfolio includes Vangara (a full-spectrum antibiotic); Bacro and Bactroperoxidase (antibiotics for respiratory tract infections); Bacterec (antibiotic for infected wounds); Toradal (antiobesity agent); Pimecanolamine D3; Aktiv (antioxidant); and other products.